Matches in SemOpenAlex for { <https://semopenalex.org/work/W4387492765> ?p ?o ?g. }
- W4387492765 abstract "Abstract Background While rigorous randomized clinical trials have substantiated the efficacy of COVID-19 vaccines in reducing hospitalization and mortality rates, there is a paucity of post-authorization analyses conducted in real-world settings. In Venezuela, the primary vaccines administered are Sinopharm and Sputnik-V. However, the performance and effectiveness of these vaccines within this specific population remain to be thoroughly investigated. Methods A prospective cohort study was undertaken from October 5, 2021, to March 31, 2022, across four sentinel hospitals in Venezuela. The outcomes were evaluated at two time points: day 28 and day 48, utilizing the WHO’s COVID-19 Clinical Progression Scale. For the purpose of analysis, patients were classified into two groups: vaccinated and unvaccinated. Results The study included a total of 175 patients, of which 85 (48.6%) were categorized as vaccinated, with the majority (76.5%) having received two doses. The median age of the patients was 68 years, with a slight predominance of females (53.1%), and the majority being unemployed/retired (60.6%). Hypertension (53.1%) and diabetes (18.3%) were the most prevalent comorbidities. The median Charlson index of the patients was 3 points, with no statistically significant differences observed between the groups ( p = 0.2). Upon admission, dyspnea was more commonly observed in unvaccinated patients compared to vaccinated patients (76.7% vs. 62.4%, p = 0.039). Almost all laboratory parameters were comparable in both groups, with the exception of the median D-dimer level, which was significantly higher in unvaccinated patients (7.6 vs. 1.4 µg/mL, p = 0.015). A total of 50 patients (28.6%) died of the disease, with a higher proportion of deaths observed in unvaccinated patients compared to vaccinated patients (35.6% vs. 21.2%, p = 0.035). Factors such as advanced age (OR = 1.043, 95%CI = 1.015–1.071, p = 0.002) were associated with increased odds of death, while factors such as vaccination against COVID-19 (OR = 0.428, 95%CI = 0.185–0.99, p = 0.047), high oxygen saturation (OR = 0.964, 95%CI = 0.934–0.995, p = 0.024), and enoxaparin administration (OR = 0.292, 95%CI = 0.093–0.917, p = 0.035) were associated with decreased odds of death. Conclusion In the course of the third and fourth waves of the pandemic, vaccination against COVID-19 was found to be associated with a 57% reduction in mortality among patients treated in four public hospitals in Venezuela." @default.
- W4387492765 created "2023-10-11" @default.
- W4387492765 creator A5001655944 @default.
- W4387492765 creator A5005150577 @default.
- W4387492765 creator A5006383787 @default.
- W4387492765 creator A5011255778 @default.
- W4387492765 creator A5013288521 @default.
- W4387492765 creator A5041457843 @default.
- W4387492765 creator A5042583386 @default.
- W4387492765 creator A5046577599 @default.
- W4387492765 creator A5056096593 @default.
- W4387492765 creator A5058489314 @default.
- W4387492765 creator A5064929424 @default.
- W4387492765 creator A5067777707 @default.
- W4387492765 creator A5072741970 @default.
- W4387492765 creator A5076928439 @default.
- W4387492765 creator A5080662179 @default.
- W4387492765 creator A5092738446 @default.
- W4387492765 creator A5092738447 @default.
- W4387492765 creator A5093035123 @default.
- W4387492765 creator A5093035124 @default.
- W4387492765 creator A5093035125 @default.
- W4387492765 date "2023-10-10" @default.
- W4387492765 modified "2023-10-12" @default.
- W4387492765 title "COVID-19 Vaccination and Mortality Reduction: A Prospective Cohort Study in Venezuela" @default.
- W4387492765 cites W2000445173 @default.
- W4387492765 cites W3001118548 @default.
- W4387492765 cites W3002108456 @default.
- W4387492765 cites W3006485704 @default.
- W4387492765 cites W3009885589 @default.
- W4387492765 cites W3016785135 @default.
- W4387492765 cites W3019196601 @default.
- W4387492765 cites W3019406601 @default.
- W4387492765 cites W3022937080 @default.
- W4387492765 cites W3034858522 @default.
- W4387492765 cites W3037231227 @default.
- W4387492765 cites W3042021285 @default.
- W4387492765 cites W3102607462 @default.
- W4387492765 cites W3131688063 @default.
- W4387492765 cites W3137209235 @default.
- W4387492765 cites W3165656738 @default.
- W4387492765 cites W3177025353 @default.
- W4387492765 cites W3178148912 @default.
- W4387492765 cites W3182171326 @default.
- W4387492765 cites W3192697308 @default.
- W4387492765 cites W3202637221 @default.
- W4387492765 cites W3203100215 @default.
- W4387492765 cites W3208400521 @default.
- W4387492765 cites W3211051404 @default.
- W4387492765 cites W3212656483 @default.
- W4387492765 cites W3214063721 @default.
- W4387492765 cites W3216941935 @default.
- W4387492765 cites W4205797283 @default.
- W4387492765 cites W4206179867 @default.
- W4387492765 cites W4206292713 @default.
- W4387492765 cites W4280580558 @default.
- W4387492765 cites W4281703308 @default.
- W4387492765 cites W4281741875 @default.
- W4387492765 cites W4288053888 @default.
- W4387492765 cites W4292582524 @default.
- W4387492765 cites W4310183461 @default.
- W4387492765 cites W4366985333 @default.
- W4387492765 doi "https://doi.org/10.21203/rs.3.rs-3396851/v1" @default.
- W4387492765 hasPublicationYear "2023" @default.
- W4387492765 type Work @default.
- W4387492765 citedByCount "0" @default.
- W4387492765 crossrefType "posted-content" @default.
- W4387492765 hasAuthorship W4387492765A5001655944 @default.
- W4387492765 hasAuthorship W4387492765A5005150577 @default.
- W4387492765 hasAuthorship W4387492765A5006383787 @default.
- W4387492765 hasAuthorship W4387492765A5011255778 @default.
- W4387492765 hasAuthorship W4387492765A5013288521 @default.
- W4387492765 hasAuthorship W4387492765A5041457843 @default.
- W4387492765 hasAuthorship W4387492765A5042583386 @default.
- W4387492765 hasAuthorship W4387492765A5046577599 @default.
- W4387492765 hasAuthorship W4387492765A5056096593 @default.
- W4387492765 hasAuthorship W4387492765A5058489314 @default.
- W4387492765 hasAuthorship W4387492765A5064929424 @default.
- W4387492765 hasAuthorship W4387492765A5067777707 @default.
- W4387492765 hasAuthorship W4387492765A5072741970 @default.
- W4387492765 hasAuthorship W4387492765A5076928439 @default.
- W4387492765 hasAuthorship W4387492765A5080662179 @default.
- W4387492765 hasAuthorship W4387492765A5092738446 @default.
- W4387492765 hasAuthorship W4387492765A5092738447 @default.
- W4387492765 hasAuthorship W4387492765A5093035123 @default.
- W4387492765 hasAuthorship W4387492765A5093035124 @default.
- W4387492765 hasAuthorship W4387492765A5093035125 @default.
- W4387492765 hasBestOaLocation W43874927651 @default.
- W4387492765 hasConcept C126322002 @default.
- W4387492765 hasConcept C187212893 @default.
- W4387492765 hasConcept C188816634 @default.
- W4387492765 hasConcept C203014093 @default.
- W4387492765 hasConcept C22070199 @default.
- W4387492765 hasConcept C2779134260 @default.
- W4387492765 hasConcept C2908647359 @default.
- W4387492765 hasConcept C3008058167 @default.
- W4387492765 hasConcept C524204448 @default.
- W4387492765 hasConcept C535046627 @default.
- W4387492765 hasConcept C71924100 @default.
- W4387492765 hasConcept C72563966 @default.